Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jan 1;12(2):371–378. doi: 10.7150/jca.40802

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The author(s)

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.

PMC Copyright notice

MRI of the patient, HE staining and immunohistochemisty of the patient tissue and SHG140 intracranial xenografts. A1: The first post-surgery contrast-enhanced MRI, A2: The second pre-surgery contrast-enhanced MRI, A3: The second post-surgery contrast-enhanced MRI. A4: HE staining of the first surgery, A5: HE staining of the second surgery. A6-A11: Immunohistochemical staining of GFAP, Nestin, Olig-2, S-100, Ki67 and Vimentin in patient tissue. B1: HE staining of mouse intracranial xenograft (X40), B2: HE staining of mouse intracranial xenograft, the left part of image displayed the invasive tumor of the intracranial xenograft, the right part of image displayed the intracranial xenograft(X100), B3: HE staining in the blue frame from B2 (X400), B4: HE staining in the red frame from B2 (X400). B5-B10: Immunohistochemical staining of GFAP, Nestin, Olig-2, S-100, Ki67 and Vimentin in naked-mouse intracranial xenograft.